Q: Who is the ideal candidate for tirzepatide over semaglutide
This triple agonism distinguishes retatrutide from existing approved agents such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 agonist)
For the scores of people seeing weight loss success on prescription injectables such as Ozempic, Wegovy, Saxenda, and others, the number on the scale isnt the only change theyre experiencing
Clinical Trial Dosing Data AOD-9604 has been evaluated across multiple administration routes and dosing regimens
Vinogradova, Y., Coupland, C
You may recall another of our At a glance factsheets , also by Steve Bain, outlining the evidence regarding diabetic retinopathy in users of GLP-1 RAs, with recommendations on safe use